What Should Clinics Look for in an RPM Vendor Security Checklist in 2026?

A Practical RPM Vendor Security Checklist for Clinics and Care Networks

A remote patient monitoring vendor security checklist should help a clinic decide whether a SaaS platform can protect patient-generated data, support HIPAA compliance, and operate reliably during a clinical disruption. The evaluation should cover more than encryption: it should also test identity controls, access permissions, audit evidence, incident response, data retention, subcontractor management, business continuity, and the vendor’s willingness to sign appropriate contractual protections. For care networks, the same review may need to address multiple locations, clinical teams, EHR integrations, and patients with limited digital access. The checklist should produce evidence that can be reviewed by privacy, security, clinical, compliance, and procurement personnel rather than a generic score created by the salesperson. As of October 2, 2026, healthcare buyers should treat remote monitoring as an operational technology service, not simply a patient-engagement application.

Also worth reading: What Should a Remote Patient Monitoring Security Evidence Checklist Prove in 2026? · What Is the RPM Billing Compliance Checklist for Clinics in 2026? · What should clinics include in a FHIR implementation checklist before connecting EHR, patient-pulse, and care-coordination systems?

No single certification or questionnaire guarantees security. HIPAA does not certify vendors, and the HIPAA Security Rule does not prescribe one universal vendor checklist. Instead, organizations must determine whether reasonable and appropriate safeguards exist for their own risks, size, complexity, and patient population. A platform may be technically strong but still unsuitable if it cannot support required audits, contract terms, data-location requirements, or workflows. The practical goal is therefore to establish a documented control baseline and a process for reviewing exceptions. The program should connect technical controls with the administrative and physical safeguards that a clinic or care network must manage.

What the Checklist Must Establish

The first requirement is lawful handling of electronic protected health information. The vendor should explain what information it receives, why it processes that information, and how long it retains it. A remote monitoring program may involve identifiers, diagnoses, medication information, vital signs, device identifiers, messages, appointment details, billing data, and sometimes recordings or images. The checklist should distinguish between information needed for treatment, information needed for billing, and information retained merely for analytics or product improvement. A vendor should not assume that every data element belongs in every workflow. Data minimization reduces the number of records exposed if an account is compromised, although it must be balanced against the clinical need to retain trends and support continuity of care.

The vendor should describe its encryption practices in measurable terms. Ask whether data is encrypted in transit and at rest, which protocols are supported, how keys are managed, and whether older or nonstandard integrations are blocked. TLS 1.2 or later is a reasonable minimum expectation for modern external connections, but the certificate policy and endpoint configuration matter as much as the protocol name. The vendor should also explain how device communications, mobile applications, browser sessions, backups, exports, and support tools are protected. Encryption does not replace access control, logging, patching, or employee training. A checklist that records only “AES-256” or “TLS” is incomplete because it does not reveal who can decrypt data, where keys are stored, or how exceptions are monitored.

Identity and access controls deserve particular attention because remote access can expose an entire patient panel to one compromised account. The preferred baseline is phishing-resistant multifactor authentication, such as FIDO2 or WebAuthn passkeys, for administrators and high-risk users; short time-based one-time passwords can be an acceptable interim control where passkeys are not supported. Accounts should use role-based access, least privilege, prompt revocation, and periodic access reviews. Privileged actions, such as exporting data, changing retention settings, managing users, or viewing audit logs, should require stronger controls and produce attributable records. A vendor should be able to demonstrate a tested process for disabling a departing employee within one business day and reviewing unusual login attempts.

Security Controls to Verify

A useful checklist asks for evidence, not promises. The vendor should provide a current SOC 2 Type II report, penetration-test summary, secure-development lifecycle description, vulnerability-management policy, and incident-response plan when those materials are available. A SOC 2 report can offer useful information about control operation over a review period, but it does not replace a buyer’s risk analysis or prove that every product and customer environment is equally secure. The vendor should identify the legal entity and product covered by the report, the review period, any exceptions, and whether the report can be shared under confidentiality terms. A clinic should also ask for remediation deadlines tied to severity, rather than accepting a general statement that vulnerabilities are fixed “regularly.”

The program should establish measurable patch and vulnerability expectations. Ask whether critical vulnerabilities are addressed within a defined window, such as 7 days for actively exploited internet-facing flaws and 30 days for high-risk flaws when mitigation is not immediate, while recognizing that actual timelines depend on severity, exploitability, vendor dependencies, and clinical risk. The vendor should describe asset inventory, dependency scanning, code review, separation of production and test environments, and testing before material releases. Medical-device connections require extra care: the software vendor’s security controls do not automatically make the device safe. Buyers should ask who is responsible for device identity, firmware maintenance, certificate rotation, and notification when a device or communication channel becomes unsupported.

Auditability is a practical control, not paperwork. Logs should capture authentication, authorization failures, record views, exports, administrative changes, configuration changes, and security events, with timestamps that support incident investigation. The vendor should state how long logs are retained, who can access them, and whether customers can retrieve them for a compliance investigation. A minimum retention period may be determined by organizational policy and contractual requirements; six to twelve months is often more useful for a security program than a few weeks, but HIPAA does not prescribe one universal log-retention period. Log access itself should be restricted, because logs may reveal usernames, device identifiers, staff behavior, and system configuration.

## Privacy, Data Use, and Patient Trust

Remote monitoring creates privacy questions that differ from ordinary business software. Patients may be monitored at home, sometimes by family members, and may not realize that their vital-sign data is visible to multiple clinical teams or vendor personnel. The vendor should support minimum-necessary access, clear patient notices, consent workflows where required, and documented procedures for correcting or deleting information when organizational policy permits. The clinic should decide whether de-identified or aggregated data may be used for quality improvement, analytics, research, or model training, and those decisions should appear in the business associate agreement or related contract. A vendor that uses customer data for unrelated commercial purposes should be willing to state that clearly and provide contractual restrictions.

The data-retention question should be answered with numbers. The buyer should identify how long raw vital signs, derived alerts, messages, recordings, device identifiers, and audit logs remain available, including in backups. Deletion from the active system does not necessarily erase every copy immediately, so the vendor should explain backup rotation and eventual destruction. A reasonable starting point is to align retention with clinical, legal, financial, and security needs rather than retaining all data indefinitely. For example, a clinic might review whether alert records older than 24 months remain necessary after the legal and clinical requirements are assessed. The exact period is not a universal HIPAA rule, and deleting too aggressively can impair safety investigations or continuity of care.

Patient access is also a security control. Patients should be able to use unique accounts or verified recovery methods, and support staff should not rely on predictable passwords or unverified phone calls to reset accounts. The vendor should provide accessible, age-appropriate instructions and support patients who use shared devices or low-bandwidth connections. If a patient can invite a caregiver or proxy, the system should make that relationship visible, revocable, and limited to appropriate information. Care networks should test whether small practices and community clinics can maintain consistent settings without requiring every site to create a separate, incompatible workflow.

Contracts, Business Associates, and Responsibility Boundaries

Before go-live, the clinic should execute a business associate agreement with the vendor when the vendor creates, receives, maintains, or transmits protected health information on its behalf. The agreement should address permitted uses, safeguards, incident notification, subcontractors, individual-rights support, return or destruction of information, and other required provisions. The security checklist should then translate contractual promises into operational evidence. A clause that requires “commercially reasonable safeguards” is less useful when the contract does not identify reporting contacts, evidence rights, remediation expectations, or consequences for unresolved material risk.

The vendor should disclose subcontractors and fourth parties that may handle hosting, messaging, device data, support, analytics, or clinical operations. A clinic does not need an unreasonable list of every technology provider, but it should know which parties can access ePHI and how the vendor oversees them. Contracts should also state whether data is hosted in the United States or another jurisdiction, although storage location alone does not determine compliance. The parties should agree on incident-notification timing. A practical target is immediate notice after confirmation of a security incident affecting protected data, followed by updates as facts become reliable; buyers should not accept an undefined period measured only from the vendor’s internal investigation.

Liability and insurance terms deserve review by counsel. A breach can involve notification costs, remediation, forensic work, lost revenue, and regulatory consequences. The agreement should clarify responsibility for notification, credit monitoring where appropriate, data restoration, cooperation, and costs. It should also state how the vendor will handle a material change in control, such as acquisition, bankruptcy, a new hosting provider, or discontinuation of the product. Exit planning is part of security planning. The clinic should know how it obtains its data, in what format, how quickly, and at what cost, and whether the vendor will cooperate with migration to another provider.

Availability, Integrations, and Business Continuity

Remote monitoring can affect care when a platform is unavailable, alerts are delayed, or data is lost. Before deployment, define recovery time objectives and recovery point objectives with the vendor. A clinical platform may need a recovery time objective of several hours for urgent workflows, while a noncritical reporting feature may tolerate longer interruption. Recovery point objectives should reflect how much monitoring data can safely be lost. If continuous vital-sign monitoring is clinically important, a backup system that loses a full day may not be acceptable. The vendor should provide evidence from restoration tests, failover exercises, and incident postmortems rather than only an uptime percentage.

The vendor should report uptime in a way that distinguishes planned maintenance, partial degradation, and total outage. A monthly uptime figure of 99.9% permits roughly 43 minutes of unavailability over a 30-day month; 99.95% permits about 21.6 minutes. Those figures are mathematical examples, not proof that a specific service meets the clinic’s needs. Ask whether the metric covers the entire workflow, including mobile access, alerts, integrations, API endpoints, and notification delivery. A clinic may also need service-level credits, support response targets, escalation contacts, and a clear process for communicating widespread outages to clinicians and patients.

Integrations with EHRs, billing systems, identity providers, and medical devices should be tested under realistic failure conditions. Ask what happens when an interface token expires, a field changes, a patient is transferred between locations, or duplicate records are created. The platform should not silently drop alerts. Alert thresholds, units, time zones, and device assignments should be validated before clinical use, with a documented process for correcting misrouting or duplicate monitoring. For care networks, one multi-tenant configuration may be simpler than separate instances, but the buyer should understand how tenant isolation, role boundaries, data segregation, and customer-specific retention are enforced.

Cost, Vendor Types, and Buying Decisions

Security can affect both price and total cost of ownership. Vendors may charge for advanced authentication, audit exports, custom retention, dedicated environments, premium support, device connectivity, implementation, validation, and API usage. Subscription pricing alone can be misleading because a clinic may also pay for onboarding, clinician training, patient support, integration work, security reviews, and ongoing monitoring. Ask for a three-year cost model that includes seat changes, device volume, message limits, data export, renewal increases, and termination assistance. A low monthly price may be attractive for a small clinic, while a care network may prefer an annual commitment if it receives administrative features and predictable support.

The lowest bidder should not automatically win, and the most feature-rich product should not automatically receive approval. A smaller vendor may provide excellent support but have limited security staffing; an enterprise vendor may offer stronger documentation but impose a costly procurement cycle. Ask each vendor to explain which claims are included in the proposed product, which require an add-on, and which are delivered by a subcontractor. Security evidence should be current, and the buyer should verify that the proposed environment matches the environment discussed during the review.

When to Act and How to Avoid Common Mistakes

A clinic should begin the security review before signing a pilot agreement, especially when the vendor will connect to an EHR, receive ePHI, or communicate patient data by SMS or email. A short proof of concept can be useful, but it should not bypass contract, privacy, and security approval. If the program cannot wait for a full review, limit the pilot to a small number of users, use synthetic test data where possible, avoid unnecessary identifiers, and define an end date. The clinic should also decide who owns the decision: one security lead may coordinate, but clinical operations, privacy, legal, procurement, and IT should participate because no single department can assess every risk.

Common mistakes include accepting a security questionnaire without checking scope, treating SOC 2 as a guarantee, asking only whether data is encrypted, failing to define alert availability, or approving a demo that does not match production. Another mistake is comparing vendors using different questions. A structured checklist should assign an owner and due date to each item, record missing evidence, and set a deadline for closing high-risk gaps. Material exceptions should be escalated before go-live, with an interim control or a decision not to proceed. The review should be repeated after a major product change, new integration, acquisition, new device family, or incident.

The final decision should be time-bounded. A reasonable target is to complete initial evidence collection within 30 days, close high-risk findings within 60 to 90 days, and conduct a formal review before any major expansion. Those are planning targets, not legal deadlines. If a vendor cannot provide a business associate agreement, identify accountable security personnel, explain incident reporting, or answer basic data-location and deletion questions, the organization should pause rather than treating the uncertainty as a minor paperwork issue. For a care network, approval may be appropriate for one site and not another if staffing, patient population, integrations, or risk differs.

A Decision Framework for getpulse.care

For getpulse.care and similar care-coordination platforms, the central question is whether the product makes clinical communication more reliable without making privacy and security management harder for the clinic. A useful evaluation begins with the intended workflow: which patients are monitored, which staff receive alerts, what happens when a reading is out of range, and what evidence shows that an alert reached the right person. The platform should then be tested against access controls, audit logs, integration failures, recovery behavior, patient identity, data export, and vendor support. Security should be evaluated as part of care quality rather than as a separate procurement ritual.

The strongest evidence is usually a combination of documentation and observation. Read the business associate agreement, examine the current assurance materials, review the incident process, and test role permissions in a realistic account. Ask for a demonstration of audit exports, account revocation, retention changes, backup restoration, and notification escalation. Confirm whether a promised feature is generally available, limited release, pilot-only, or dependent on a third-party service. For patient-pulse SaaS used by clinics and care networks, these checks help reveal whether the platform can support safe operations across different locations without assuming that every customer has the same technical environment.

Ultimately, a vendor passes the checklist only when its protections, contracts, and operational practices fit the clinic’s risk tolerance and documented needs. Passing does not mean the vendor is risk-free; failing does not always mean the product is unusable. The right decision is a transparent one based on evidence, unresolved risks, compensating controls, and a clear owner for remediation. The date of October 2, 2026 does not change the underlying standard: remote patient monitoring software should be secure enough to support dependable care, accountable access, and rapid response when technology or patient data is at risk.